National
Media missteps after Charlie Kirk shooting put trans community at risk: advocates
As false media narratives began to spread about the Kirk’s suspected shooter, they endanger the transgender community.
Charlie Kirk, one of the country’s most prominent right-wing political commentators and founder of Turning Point USA, was shot and killed last week while attending an event at Utah Valley University in Orem, Utah. Kirk, 31, had become a defining voice for a new generation of conservative activists—championing Trumpism, attacking LGBTQ rights, railing against immigration, and amplifying culture war rhetoric that earned him both loyal followers and passionate detractors.
Since his death, media outlets from all sides of the political spectrum began to look for any details that could speak to the killer’s motive. In that rush to be the first to cover unknown details about the alleged shooter, who we now know to be Tyler Robinson, 22, multiple outlets began publishing information that had not been vetted or checked by law enforcement.
Early reports incorrectly linked the suspected shooter to the transgender community, with several outlets citing unverified social media accounts, anonymous chatter, and suspected “antifascist” and “transgender ideology” inscribed onto bullets that had come from an early law enforcement bulletin. One outlet in particular — the Wall Street Journal — took a hardline approach to publishing this early, unvetted information. They went as far as to claim there was a direct link to the shooter and the transgender community in an article that has since been demanded to be taken down by the largest LGBTQ rights advocacy group, the Human Rights Campaign.
The National Association of LGBTQ+ Journalists (NLGJA), a professional organization advocating for LGBTQ journalists and issues in the media, responded to the Blade’s request for comment. President Ken Miguel said in an email:
“Whenever there is a terrible act of violence, newsrooms are faced with sorting rumor from fact. Unfortunately, the desire to be first sometimes gets in the way of being fair and accurate. In recent days, The Wall Street Journal and The New York Post reported ‘sources’ linking Charlie Kirk’s killing with ‘transgender and antifascist ideology.’ Many other outlets had access to similar sources but waited for confirmation from those closest to the investigation.
Sharing unsubstantiated claims breaks one of journalism’s core ethical principles: do no harm. NLGJA: The Association of LGBTQ+ Journalists is reaching out to the leadership of these papers to discuss the damage caused by this kind of coverage. Stories like these risk reinforcing harmful stereotypes and unfairly targeting a marginalized group that has already been the subject of politically motivated attacks. … Terms such as “transgender ideology” are rooted in political rhetoric, not neutral descriptions of identity, and should be handled with care, clear attribution, and context.”
In reality, investigators have confirmed that Robinson was raised in a staunchly MAGA household, with no indication he came from a “leftist” or progressive background, despite some outlets’ early claims. Law enforcement officials also confirmed that Robinson’s roommate — described by friends as a possible romantic partner — is transgender and has been cooperating fully with authorities since the shooting and knew nothing of Robinson’s alleged plan to kill Kirk.
The claim of connection to the transgender community was baseless, but it was amplified widely before any confirmation. By the time the outlet issued an editor’s note– and not removing the story like HRC had asked, the narrative had already taken root, reinforcing damaging stereotypes and giving far-right figures fresh ammunition to escalate their ongoing campaign of anti-trans rhetoric.
“This is another example of an incident where they should be focusing on gun violence, but instead they lean into scapegoating a community—this time not just without facts, but with bad facts. That does real harm to people who are already vulnerable,” said Cathy Renna, longtime communications director for the National LGBTQ Task Force.
Her frustration speaks to a broader pattern. In moments of crisis, particularly those involving mass violence, trans and queer people often become the subject of rumor, scapegoating, and speculative reporting — regardless of evidence. The Kirk shooting proved no different, exposing both the fragility of media responsibility in the digital age and the persistence of anti-trans narratives that continue to shape American discourse.
For Brandon Wolf, press secretary for the Human Rights Campaign and a survivor of the Pulse nightclub massacre, the media’s role in amplifying false connections between the Kirk shooter and “trans ideology” is not just bad reporting — it is life threatening.
“Words have consequences, and escalating dehumanizing and dangerous rhetoric against transgender people leads to physical harm,” Wolf said. “We’ve seen it over and over again. People in power can’t pretend they don’t know what their words unleash.”
Kirk’s killing, he argued, should have been a moment for the country to reckon with its epidemic of gun violence. Instead, it became another flashpoint in the culture wars, with the right exploiting misinformation to vilify an already marginalized community.
“The right wing is breathlessly obsessed with transgender people—using them as scapegoats for everything from the price of eggs to immigration policy. It’s not about policy, it’s about power, and they’re willing to sacrifice real lives in the process,” Wolf added.
That obsession, he noted, has consequences far beyond social media posts and podcasters pushing divisive language. From all levels of the country trans people are being legislated out of public life — targeted with bans on healthcare, sports participation, and restroom use. Each false narrative layered onto that environment increases the danger.
For both Wolf and Renna, the issue is not only political opportunism but also a profound failure of journalistic responsibility.
“Journalists have a responsibility to get it right, not just to get it first. When the wrong narrative takes off, it spreads like wildfire, and the truth never fully catches up. That puts people’s lives at risk,” Wolf said.
Renna agreed, stressing that the problem is systemic.
“Editors and producers make decisions every single day that impact us, and too often they’re choosing speed over accuracy, headlines over accountability,” Renna said. “That’s not just sloppy journalism—it’s irresponsible, and it costs people their safety.”
Her critique echoes years of advocacy work around media representation. As a veteran of LGBTQ communications strategy, Renna has worked directly with newsrooms to encourage fair and accurate coverage. She described the Kirk shooting coverage as a textbook example of what happens when fact-checking is abandoned for the sake of virality.
“The media is a powerful force in shaping public opinion and even people’s realities. When misused, it has a truly detrimental effect. A single inaccurate headline can reinforce stereotypes and feed dangerous narratives for years,” she said.
This disheartening example underlines a sad yet all too familiar truth– marginalized communities are often the first to be blamed when tragedy strikes.
“The most heinous part of scapegoating is that it usually targets those who are already the most vulnerable—trans folks, people of color, women. It’s punching down at people who already live under threat,” Renna said.
The impact of such scapegoating extends beyond headlines, both Wolf and Renna said. When false claims tie trans people to acts of violence, it fuels harassment online, increases the likelihood of physical violence, and deepens public misunderstanding.
“It’s unfair to the public not to fully inform them of all the parts of a story—and in this case, parts of the story weren’t just missing, they were flat-out wrong. That damages trust in the media at a time when trust is already fragile,” Renna added.
Wolf warned that this devolution of trust, and on the importance of facts in journalism feeds into broader democratic instability in America. “The never-ending livestream of gun violence in this country is really disturbing. Our brains were never meant to process that much violence and death on display at all times, and the desensitization is dangerous for democracy,” he said.
While much of the public debate after Kirk’s death centered on politics and identity, advocates stressed that the real crisis remains America’s gun epidemic.
“Gun violence should never be normal in this country. That’s not democracy. That’s not American freedom, and it’s certainly not safety,” Wolf said.
As a survivor of Pulse, Wolf’s perspective adds a unique and pointed weight. He has spent years urging lawmakers to enact reforms, all while seeing firsthand the trauma that survivors and communities endure long after headlines fade. For him, the fact that Kirk — a figure known for fanning the flame of divisiveness in the country – fell victim to the very violence he often downplayed should have been an opening for sober reflection on national priorities.
Instead, Wolf said, the narrative was taken over by people more interested in weaponizing mis- and disinformation than preventing the next tragedy.
“Political violence is never the answer. We don’t defeat hate by doubling down on it. If we want to end the cycle, we have to commit ourselves to building something better,” he said.
Renna said the Kirk shooting coverage should serve as a wake-up call for the media industry. The rush to link violence to marginalized groups, she said, reflects deeper biases that must be addressed.
“The immediate rush to report things without verifying them has become a huge problem across coverage of trans issues. It’s not just bad journalism—it actively puts people in danger,” she warned.
Advocates like Renna and Wolf are urging both media leaders and the public to demand better. For journalists, that means investing in fact-checking, slowing down when information is unverified, and considering the real-world consequences of framing choices. For the public, it means resisting the urge to amplify unconfirmed narratives and holding outlets accountable when they fail.
The stakes could not be higher, especially for transgender people. Anti-trans rhetoric has already been linked to rising violence against LGBTQ people nationwide.
The assassination of Charlie Kirk was a shocking moment in American politics, one that should have sparked urgent conversations about gun violence, political extremism, and the health of democracy. Instead, misinformation and scapegoating shifted the focus onto one of the nation’s most vulnerable communities and continues to dominate headlines.
For Wolf and Renna, the lesson is clear: until the media take its responsibility more seriously, trans people will continue to bear the brunt of careless reporting and opportunistic politics.
“Words have consequences,” Wolf reminded. And when those words are wielded recklessly in the wake of tragedy, the consequences can be deadly.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
